Skip to main content
. 2021 Jul 1;12:656115. doi: 10.3389/fphar.2021.656115

FIGURE 4.

FIGURE 4

Enrichment analysis of core targets of SNS in treating liver fibrosis based on Omicshare. A p-value cut-off of ≤0.05 was considered significant and the hyper-geometric test applied to identify enriched GO-BP terms (A) and KEGG pathways (B).